“Burning Mouth Syndrome and Salivary Brain Derived Neurotrophic Factor Level in Type 2 Diabetes Mellitus Patients on Metformin Monotherapy and on Combination of Metformin and Glibenclamide (A Comparative Study)”, Indian Journal of Forensic Medicine & Toxicology, vol. 14, no. 2, pp. 2106–2112, Apr. 2020, doi: 10.37506/ijfmt.v14i2.10552.